Introduction
The first and perhaps the most crucial step in initiating a cycle of infection by any viral pathogen is the recognition of host cell receptors (Crowell, 1987) . Viruses bind to one or more host cell molecules that are normally present on a limited number of host cell types only. In general, the presence or absence of specific cellular receptors influences the host range, tissue tropism and the disease symptoms produced by a virus. The cellular receptors of several enveloped and non-enveloped viruses have been identified. Most such receptors identified so far are glycoproteins, although viruses can use lipids or carbohydrates as their receptors (Markwell et al., 1981; Weis et al., 1988) . Some of the receptors that have been identified are cell surface molecules of known functions (Dalgleish et al., 1984; Klatzman et at., 1984; Co et al., 1985; Breau et al., 1992; Delmas et aI., 1992; Yeager et al., 1992) , the normal functions of others are unknown (Xue & Minocha, 1993) . A number of these receptors have been identified by the use of viral glycoproteins, anti-receptor antibodies or anti-idiotypic antibodies (anti-ids) mimicking viral epitopes involved in attachment or penetration (Noseworthy et al., 1983; Co et al., 1985; Marriott et al., 1987; Wang et al., 1991; Xue & Minocha, 1993) . In this report, we describe the identification of a putative cellular receptor for bovine herpesvirus 1 (BHV-1) with anti-ids mimicking an epitope involved in virus penetration of host cells.
BHV-1, an alphaherpesvirus, is one of the important aetiological agents of the bovine respiratory disease complex (Wohlgemuth & Herrich, 1987) , BHV-1 infection usually does not result in the death of animals, but may immunocompromise them which invariably leads to secondary bacterial pneumonia (Yates et al., 1983) . In addition to respiratory disease, BHV-1 can also cause genital disease (vulvovaginitis and balanoposthitis), abortion, conjunctivitis and less frequently encephalitis and generalized systemic infections (Yates, 1982) . Because of its important role in bovine respiratory disease, routine vaccination with modified live virus (MLV) vaccines is widely practised. MLV vaccines, however, have the disadvantage of establishing latent infections, like the wild-type virus, with potential for reactivation and shedding of the virus (Rouse & Babiuk, 1978; Nettleton & Sharp, 1980; Pastoret et al., 1980) . Identification of the cellular receptor(s) used by the virus to establish infection would lead to better understanding of the pathogenesis of BHV-1 disease.
Alphaherpesviruses infect cells by first attaching to a receptor on the permissive cell surface. This step is followed by virus penetration involving membrane fusion. These two steps together lead to the process of viral entry (Lentz, 1990; Roizman & Sears, 1990) . In the case of BHV-1, the major envelope glycoproteins gI, gIII and gIV, the homologues of herpes simplex virus (HSV) gB, gC and gD, have been suggested to mediate these functions (Liang et al., 1991) . The initial attachment of BHV-1 to cells is via the interaction of gIII with heparinlike moieties (Okazaki et al., 1991) . This interaction with heparin may also be mediated by gI and/or gIV, since gIII deletion mutants can infect cells, although at a reduced rate (Liang et al., 1992) . In the HSV system, mutants lacking gD attach to host cells, but do not enter them (Johnson & Ligas, 1988) . Furthermore, gD present on the plasma membrane of cells that constitutively express this glycoprotein interferes with the penetration of superinfecting HSV (Campadelli-Fiume et al., 1988 , 1990 , suggesting a definite role for gD in penetration of host cells. Direct evidence for the role of BHV-1 gIV (the homologue of HSV gD) in host cell penetration comes from the studies in which bovine fibroblasts expressing glV on their surface showed decreased virus production in comparison to normal fibroblasts (Chase et al., 1990; Chase & Letchworth, 1994 ). Fehler et al. (1992 have further demonstrated that BHV-1 glV is essential for virus entry and the amount of glV in the viral envelope influences the efficiency of the virus penetration process. These observations clearly indicate a crucial role for gIV in the penetration event. In this study, we have used anti° ids specific for an anti-gIV monoclonal antibody (MAb) that inhibits BHV-1 penetration but does not inhibit attachment, in order to identify a cellular receptor utilized by BHV-1 for penetration of permissive host cells.
Methods
Cells. Madin-Darby bovine kidney (MDBK) and bovine lung cells were propagated in Dulbecco's modified Eagle's minimal essential medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 20 gg/ml gentamicin (all from Gibco-BRL). The McClurkin swine testicular cell line (ST), used to grow transmissible gastroenteritis virus (TGEV), was also cultured under the same conditions. The murine cell line SP-2/0 was propagated as suspension cultures in RDGS medium [an equal mixture of RPMI and DMEM (5 g/l of each), supplemented with 10% gammaglobulin-free horse serum, glucose (4.5 g/l), sodium bicarbonate (2.85 g/l), L-glutamine (292 mg/l) and gentamicin (20 rag/l)]. This cell line has been previously determined to be non-permissive for BHV-1 by infecting the cells with the virus and examining them for cytopathic effects. In addition, the inability of this virus to attach to SP-2/0 cells was also determined by using [35S]methionine-labelled BHV-1.
Virus. The BHV-1 (Cooper strain) was propagated in MDBK as well as bovine lung cells and purified on potassium tartrate gradients as previously described (Misra et al., 1981) . TGEV was grown in ST cells and purified by standard protocols.
Anti-idiotypic antibodies. The development and characterization of polyclonal bovine anti-ids mimicking an epitope on BHV-1 gIV has been described previously (Srikumaran et al., 1990) . These anti-ids are referred to as anti-MM-113 ids in this paper because they were developed using a MAb, MM-113, as the antibody 1. MM-113 is a murine MAb of the IgG2a isotype that recognizes an epitope on BHV-1 glV. This MAb neutralizes the virus post-adsorption.
Virus penetration inhibition assay. The virus penetration assay was performed according to the procedures of Highlander et al. (1988) with slight modifications. Actively growing confluent monolayers of MDBK cells in six-well tissue culture plates (Costar) were cooled to 4 °C and incubated for 1 h with PBS, anti-MM-113 ids or normal bovine IgG (100 lag/ml, 0.3 ml/well) in duplicate. Following this pretreatment, 150 p.f.u, of BHV-1 was added to the wells and virus was allowed to adsorb at 4 °C for 1 h. After the viral attachment step, the monolayers were washed three times with PBS and overlaid with DMEM containing 5 % FBS prior to a temperature shift to 37 °C (to allow the penetration process to proceed) in the presence of 5 % CO,. At various time points (30, 60, 90, 120 and 150 min) after the temperature shift, the monolayers were treated with citrate buffer (40 mM-citric acid, 10 mM-KC1, 135 mMNaCI pH 3-0) for 1 min to inactivate the surface-bound, non-penetrated virus. Immediately following the citrate buffer treatment, the monolayers were washed three times with PBS and overlaid with DMEM containing 1% agarose supplemented with 2 % FBS. After incubation at 37 °C for 3 to 4 days, the monolayers were fixed and stained with 0-1% crystal violet in 10% neutral buffered formaldehyde. Plaques were counted after 3 days. The plaques represent the fraction of the input virus that had penetrated the cells at each time point. The percentage of penetration inhibition was calculated as follows: penetration inhibition (%)= [(no. of plaques without the inhibitor-no, of plaques with the inhibitor) x 100]/no. of plaques without the inhibitor.
Virus attachment inhibition assay. The technique described by Johnson et al. (1984) was followed with slight modifications. Monolayers of MDBK cells grown in 24-well tissue culture plates (Costar) at 2 x 105 cells per well were cooled to 4 °C and then 100 p.1 of PBS or various concentrations (100 p.g/ml, 50 gg/ml, 25 lag/ml and 10 gg/ml) of anti-MM-113 ids or normal bovine IgG (negative control) were added to the wells in triplicate. After 1 h of adsorption at 4 °C, [35S]methionine-labelled (New England Nuclear) and tartrate gradient-purified BHV-1 in PBS containing 1% BSA albumin (PBS BSA) was added to the wells (1 x l0 b c.p.m, in 100 lal, per well). After another 1 h incubation at 4 °C, the cells were washed with PBS until no radioactivity was detected in the wash fluid. The cellbound radioactivity was then determined by lysing the cells with lysis buffer (PBS containing 1% Triton X-100 and 1% SDS, 0.2 ml/well) and measuring the radioactivity in the cell lysates using a liquid scintillation counter. The percentage of virus attachment inhibition caused by the anti-ids (or normal bovine IgG) was calculated as follows: inhibition (%)= [1-(radioactivity with inhibitor+radio-activity without inhibitor)] x 100. lmmunoprecipitation (IP) assay. MDBK cells were surface-labelled with a~sI (New England Nuclear) using lactoperoxidase as described previously (Ward, 1984) . After extensive washes, the cells were lysed with lysis buffer (PBS containing 0-5 % NP40, 1% sodium deoxycholate, 2 mM-PMSF, 2 mM-N-ethylmaleimide and 5 mM-EDTA) on ice for 15 rain and centrifuged at 10000 g for 15 rain to remove insoluble cell debris. The IP assay was performed as described by Coligan et al. (1991) with slight modifications. Briefly, the anti-ids, normal bovine IgG, BItV-1 or TGEV were coupled to cyanogen bromide-activated Sepharose 4B, according to the manufacturer's instructions (Pharmacia). The antibodies were coupled at a ratio of 6 mg per g of Sepharose and the virions were coupled at 1 x 1011 p.f.u, per g of Sepharose. Ligand-coupled Sepharose (200 I.tl) was incubated with equal volumes of iodinated MDBK cell membrane lysate in 1.5 ml sterile Eppendorf tubes. After 1 h of incubation at room temperature, the unbound radioactivity was removed by repeated washing with PBS containing 0.05 % Tween-20. The immune complexes on the Sepharose beads were solubilized in 60 gl of sample buffer, electrophoresed on 10% polyacrylamide gels and subjected to autoradiography.
Photoaffinity labelling (PAL) assay. PAL is a novel approach that has been used to identify cellular receptors for bacterial toxins (Clark & Armstrong, 1990) . In this assay, the ligand is coupled to l~SI-labelled sulphosuccinimidyl 2-para-azidosalicylamido ethyl-1,3r-dithiopropionate (SASD; Pierce). After ligand binding to putative receptor(s) on permissive cells, the a2Sl-azido group of the SASD is covalently linked to the putative receptor by activating the SASD by exposure to u.v. light. The cells are lysed and the lysate is then subjected to SDS-PAGE. The sample buffer containing 2-mercaptoethanol disrupts the disulphide bond that links the 125I-azido group to the ligand and dislodges the ligand from the receptor. After SDS-PAGE and autoradiography, the 125I-labelled receptor protein can be visualized. The PAL assay was carried out as described by Clark & Armstrong (1990) with slight modifications. All the steps were carried out in the dark with aluminium foil-wrapped glass tubes and an infrared lamp. Briefly, 100 p~l of working solu'don of SASD was added to the tubes coated with iodogen (Pierce) to which 50 laCi of Na~25I was added and kept on ice for 1 min. This labelled complex was then added to the ligands (anti-MM-113-ids, 50 lag in 500 gl; bovine IgG, 50 p.g in 500 lal; gradient-purified BHV-1, 1 x 101°p.f.u. in 500gl; gradientpurified TGEV, 10 TM p.f.u, in 500 gl) and this mixture was incubated on ice for 30 rain. From this 12sI-SASD-labelled ligand conjugate, the unincorporated radioactivity and SASD were removed by centrifugation in Centricon-30 Concentrator Tubes (Amicon) at 2000 g for 2 h and the labelled ligand concentrate was resuspended to a final volume of 1 ml in PBS.
For pretreatment with appropriate antibodies (i.e. MM-I 13 or 5A5), the antibody (50/ag in 500 tal) was added to the labelled ligand. This mixture was incubated at room temperature for 1 h. The labelled ligand or the labelled ligand pretreated with the antibodies was then added to 3 x 107 appropriate target cells (MDBK, bovine lung or SP-2/0). The labelled ligand/target cell mixture was incubated on ice for 60 rain. Following this incubation, the mixture was exposed to u.v. light (emission maximum 302 nm) for 15 rain at a fixed distance of 10 cm. Following photoactivation, the cell suspension was washed with PBS until no radioactivity was detected in the supernatant. Finally, the cell pellet was incubated with 0.6 ml of lysis buffer on ice for 1 h. The cell lysate was then centrifuged at 3000 g for 15 min. The supernatant fluid was subjected to SDS-PAGE under reducing conditions on 10% polyacrylamide gels and autoradiography was performed.
Results

Inhibition of BHV-1 host cell penetration by anti-MM-113-ids
The antibody 1, the MAb MM-113, is a virusneutralizing antibody that recognizes an epitope on BHV-1 glV (Srikumaran et al., 1990) . This MAb does not have any effect on the attachment of the virus, but does inhibit virus penetration of host cells (data not shown). Therefore the MAb MM-113 recognizes an epitope on gIV that is required for virus penetration of permissive host cell membranes. The bovine anti-MM-113 ids induce neutralizing antibodies to BHV-1. These anti-ids also bind to BHV-1 permissive cells (Srikumaran et al., 1990) , suggesting that they mimic the epitope recognized by MM-113. If these anti-ids mimic a viral epitope involved in host cell membrane penetration, then preincubation of host cells with these anti-ids should inhibit virus penetration. As shown in Fig. 1 , the anti-ids inhibited BHV-1 penetration of host cells. In the BHV-1 attachment inhibition assay (Fig. 2) , however, the anti-MM-113 ids had a slight inhibitory effect on the attachment of BHV-1 to permissive cells. This could be because of steric interference by the anti-ids with the interaction between a viral attachment domain and the corresponding cellular domain.
Immunoprecipitation of permissive cell membrane proteins by anti-MM-113 ids and BHV-1
In IP assays, the anti-ids immunoprecipitated a protein of M~ 60K from host cell membrane extracts (Fig. 3) . This 60K protein was also precipitated by BHV-1 virions, but not by the negative controls (i.e. normal bovine IgG or an irrelevant virus, TGEV). Since the IP assays with Sepharose-coupled ligands require relatively large quantities of anti-ids and viral proteins, in subsequent studies we employed the PAL technique to confirm the results of the IP assay.
Photo-affinity labelling of permissive cell membrane proteins by anti-MM-113 ids and BHV-1
The anti-ids bound to a 60K protein on MDBK cells in the PAL assay (Fig. 4) . When preincubated with the antibody 1 (MM-113), the anti-MM-113 ids failed to bind to this protein, whereas preincubation with the isotype-matched control MAb, 5A5, did not affect the binding of the 60K protein by the anti-ids. These results indicated that the binding of the 60K protein by the antiids was specific. These results encouraged us to confirm the role played by the 60K protein in virus entry by analysing BHV-1 permissive cell lines (bovine lung and MDBK) and a non-permissive murine cell line (SP-2/0), using BHV-1 as the ligand. As shown in Fig. 5 , BHV-1 did not recognize a 60K protein on non-permissive cells of murine origin (SP-2/0). This protein also was not recognized from either BHV-1 permissive or nonpermissive cells by an irrelevant virus control, namely TGEV. However, the 60K protein was recognized by BHV-1 on both permissive cell lines tested (i.e. bovine lung and MDBK cells). Preincubation of BHV-1 with an irrelevant antibody had no effect on the binding of BHV-1 to this protein. 
Discussion
Previous studies have suggested that BHV-1 a t t a c h m e n t to permissive cells is m e d i a t e d by the envelope glycoproteins gI, gIII and gIV (Liang et al., 1991) , whereas viral penetration of the host cells is m e d i a t e d by gI and gIV (Hughes et al., 1988; Fitzpatrick et al., 1990) . It has been established that initial a t t a c h m e n t o f the virus to permissive cells is via the interaction of gIII (and gI and gIV in the absence o f gIII) with heparin-like moieties on the cell surface (Okazaki et al., 1991) . Subsequent to attachment, it is likely that the virus interacts with one (or more) cell m e m b r a n e proteins via gI and gIV ( process of penetration. Therefore, our l a b o r a t o r y has focused on the development and characterization of antiids that mimic the penetration epitopes on BHV-1 gI ( H a r i h a r a n et al., 1991) and gIV ( S r i k u m a r a n et al., 
